|
Volumn 52, Issue 3, 2008, Pages 1014-1020
|
Treatment of experimental anthrax with recombinant capsule depolymerase
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT CAPSULE DEPOLYMERASE;
RECOMBINANT ENZYME;
UNCLASSIFIED DRUG;
AMES TEST;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTHRAX;
ARTICLE;
BACILLUS ANTHRACIS;
BACTERIAL MEMBRANE;
BACTERIAL SPORE;
BACTERIAL STRAIN;
BACTERIAL VIRULENCE;
CELL KILLING;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TARGETING;
ENCAPSULATION;
EXPERIMENTAL STUDY;
FEMALE;
HUMAN;
HUMAN CELL;
IN VIVO STUDY;
INFECTION PREVENTION;
MOUSE;
NEUTROPHIL;
NONHUMAN;
PERITONEUM;
PHAGOCYTOSIS;
PRIORITY JOURNAL;
PROVOCATION TEST;
SURVIVAL;
ANIMALS;
ANTHRAX;
BACILLUS ANTHRACIS;
BACTERIAL CAPSULES;
FEMALE;
GLYCOSIDE HYDROLASES;
HUMANS;
MICE;
MICE, INBRED BALB C;
NEUTROPHILS;
PHAGOCYTOSIS;
RECOMBINANT PROTEINS;
SPORES, BACTERIAL;
TREATMENT OUTCOME;
VIRULENCE;
|
EID: 40549145143
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.00741-07 Document Type: Article |
Times cited : (56)
|
References (44)
|